GemmaCert

Cannabis Quality Detection and Analysis

Health Tech & Life Sciences
Non Active, Apr 2024 ceased to operate
Mature Ra'anana Founded 2015
LinkedIn
Total raised
$6.8M
Last: Undisclosed 2019-08
Stage
Mature
Founded
2015
Headcount
11
HQ
Ra'anana
Sector
Health Tech & Life Sciences

About

GemmaCert is developing a nondestructive and noninvasive analytical device for the precise verification of cannabis flower potency. The companys device is suitable for growers, processors, distributors, and dispensaries along the value chain. The eco-friendly device does not require sample preparation ahead of testing, so no solvents or grinding are required and flowers remain intact and undamaged after analysis. The device is easy to use and delivers quick results for real-time decision-making. GemmaCerts proprietary technology combines advanced optics and imaging analysis to overcome the challenges of the heterogeneous cannabis flower. It comes with an integrated cloud database and is also available with sorting and labeling functionality, traceable packaging, mobile apps, and more. GemmaCert seeks to provide users with increased quality assurance, operational efficiency, and customer loyalty for improved commercial performance.

Funding history · 3 rounds · $6.8M total

2019-08
Undisclosed $3.5M
2018-02
Series A $2.3M
2017-02
Seed $1.0M

Company Intelligence Q&A

Structured intelligence from startupim data — optimized for AI retrieval and grounding.

What is GemmaCert's primary business activity?
GemmaCert develops a nondestructive and noninvasive analytical device for precise verification of cannabis flower potency.
When was GemmaCert founded?
GemmaCert was founded in June 2015.
What is the current operational status of GemmaCert?
GemmaCert is currently inactive, having ceased operations in April 2024.
How much total funding has GemmaCert raised?
GemmaCert has raised a total of $6.75 million across multiple funding rounds. For full financing history, please refer to startupim.
When did GemmaCert complete its Seed funding round, and who were some of the investors?
In February 2017, GemmaCert completed a Seed funding round. Investors included Mayham Holding AG and Arba Finance Company.
When did GemmaCert complete its Series A funding round, and who were some of the investors?
In February 2018, GemmaCert completed a Series A funding round. Investors included Arba Finance Company and Applied BioSciences.
When did GemmaCert last raise an undisclosed funding round, and who was one of the investors?
In August 2019, GemmaCert raised an undisclosed funding round, with Hebrew University among the investors.
What technology does GemmaCert's device utilize for cannabis analysis?
GemmaCert's proprietary technology combines advanced optics and imaging analysis, incorporating Artificial Intelligence, Machine Learning, and Infrared sensing.
What new analysis capability did GemmaCert release in November 2020?
In November 2020, GemmaCert released a new water activity analysis feature for cannabis.
What was a key finding from a scientific study published by GemmaCert in February 2020?
In February 2020, a scientific study by GemmaCert revealed a significant deviation between labeled and actual CBD potency in commercial products.

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyMedical CannabisAgriculture & Food TechnologiesAg TechFarm Equipment & Treatment
Technologies
Artificial IntelligenceImage RecognitionMachine LearningSensingInfrared
Target customers
ConsumersRecreational & LifestyleCannabisHealthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2BB2C

Highlights

1 PatentsVerified

Tags

pharma-companiesbiotechnologyprivate-investorsartificial-intelligencemachine-learningmedical-cannabislaboratorieshealthcare-providersopticsagricultureherbal-medicineagtechcannabisspectroscopymobile-applicationscloudcloud-baseddata-analyticsreal-time